(Q38123945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Alain H Litwin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

57 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

S56-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Limited uptake of hepatitis C treatment among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C in HIV-infected individuals: cure and control, right now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Public health impact of antiviral therapy for hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Need-adapted HCV-treatment setting for injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

The depiction of stigmatization in research about hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C: studying stigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C management by addiction medicine physicians: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Management of HCV and HIV infections among people who inject drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Together … to take care: multidisciplinary management of hepatitis C virus treatment in randomly selected drug users with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Capacity enhancement of hepatitis C virus treatment through integrated, community-based care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Integrated medical care for patients with serious psychiatric illness: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Successful integration of hepatitis C evaluation and treatment services with methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Outcomes of treatment for hepatitis C virus infection by primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Adherence to hepatitis C treatment in recovering heroin users maintained on methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT271

Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23884067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integrating primary medical care with addiction treatment: a randomized controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23884067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integration of viral hepatitis services into opioid treatment programs.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23884067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIT271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

23884067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23884067%20AND%20SRC:MED&resulttype=core&format=json